Sihuan Pharmaceutical Holdings Group Ltd SHPHF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.08
- Day Range
- $0.05–0.05
- 52-Week Range
- $0.05–0.13
- Bid/Ask
- $0.04 / $0.10
- Market Cap
- $419.85 Mil
- Volume/Avg
- 315 / 308
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.59
- Dividend Yield (Trailing)
- 10.50%
- Dividend Yield (Forward)
- 10.50%
- Total Yield
- 11.30%
Company Profile
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Digestive System, Anti-Infective, metabolism, Respiratory, Neurology, and Others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others to provide non- or minimally invasive medical aesthetics comprehensive solutions; the innovative medicine and other medicine segments; and the generic medicine segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 3,241
- Website
- https://www.sihuanpharm.com
Comparables
Valuation
|
Metric
|
SHPHF
|
300194
|
002437
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 15.13 | — |
Price/Book Value | 0.67 | 1.11 | 2.44 |
Price/Sales | 1.59 | 1.73 | 1.59 |
Price/Cash Flow | — | 19.31 | 14.56 |
Price/Earnings
SHPHF
300194
002437
Financial Strength
|
Metric
|
SHPHF
|
300194
|
002437
|
|---|---|---|---|
Quick Ratio | 2.50 | 1.17 | 0.78 |
Current Ratio | 2.84 | 1.85 | 0.92 |
Interest Coverage | −8.63 | 11.58 | −0.92 |
Quick Ratio
SHPHF
300194
002437
Profitability
|
Metric
|
SHPHF
|
300194
|
002437
|
|---|---|---|---|
Return on Assets (Normalized) | −4.36% | 4.42% | −7.41% |
Return on Equity (Normalized) | −10.18% | 6.75% | −16.86% |
Return on Invested Capital (Normalized) | −6.10% | 5.47% | −8.87% |
Return on Assets
SHPHF
300194
002437
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Fbswwphlp | Cpmth | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Lljpcfgb | Vfsql | $68.1 Bil | |
HLN
| Haleon PLC ADR | Ssklfryp | Zvbpf | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Kwpftrq | Lfdqr | $14.3 Bil | |
VTRS
| Viatris Inc | Ytymwrbt | Xrvj | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Lsdzgcr | Vrdrp | $11.9 Bil | |
CTLT
| Catalent Inc | Rzhfzskjn | Ddnbc | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Jshjflqk | Wwg | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Hcrlpycq | Hzq | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bqczvhrwh | Jdnpym | $3.4 Bil |